This page may not work correctly in your current browser, Internet Explorer. We recommend changing to a more modern browser before viewing this page. We recommend Chrome, Firefox, Safari, or Edge.
CCO Webinar
07/02/2025 12:30 PM ET
Summary
Lenacapavir Approval: What to Know When Selecting a PrEP Regimen
Description
Live Webinar 0.50 CME/CPE/CE/ABIM MOC
Join Clinical Care Options for a rapid response webinar on Wednesday, July 2nd to learn how recently FDA-approved lenacapvir for PrEP fits into the current landscape of HIV prevention. Attendees can earn 0.50 CME/CPE/CE/ABIM MOC credit.
If you are a physician, pharmacist, registered nurse, or advanced practice professional who provides HIV care in specialist or primary care settings, be sure to join CCO!
Colleen F. Kelley MD, MPH
Raphael J. Landovitz MD, MSc
Why attend? You will walk away with the knowledge to:
Explain how clinical trial data and US FDA approval of LEN for HIV PrEP fits in the HIV prevention toolbox
